James List from Janssen: Proven Hypothesis Provides Hope for Future Obesity Care

Even as gastric bypass continues to be a proven surgical option in the fight against the obesity epidemic work still remains to find a therapeutic option for this patient population as well.

James F. List, Global Therapeutic Area Head of Cardiovascular and Metabolism at Janssen discussed a study the company has done looking at combining two popular medications in an effort to provide even greater benefit for obese patients. List discussed the study during the annual meeting of the American Diabetes Association in New Orleans.